Trial intelligence / Profile preview

Metabolic Effects of Testosterone, Dutasteride, and Anastrazole in Obese Men

NCT00983554Phase 2Unknown

Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases
Start
Jun 2005
Primary completion
May 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of testosterone in obesity, insulin resistance (IR), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Status: unknown.

02

Drugs

testosterone
03

Conditions

obesityinsulin resistance (IR)

Beyond the preview

Go deeper on NCT00983554.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00983554.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call